Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: J Thromb Haemost. 2022 Feb 16;20(5):1256–1270. doi: 10.1111/jth.15663

Figure 4: B16 growth in immune-deficient mice is not affected by OPN status.

Figure 4:

A. Daily determination of B16 tumor volume grown on NOG-WT (blue circles), NOG-OPN-KI (green triangles) and NOG-OPN-KO (red squares) mice in the flank model. B. B16 tumor weights after sacrifice in NOG-WT, NOG-OPN-KI and NOG-OPN-KO mice in the flank model. C. Number of visible metastatic lung nodules counted in the lungs of mice sacrificed 13 days after tumor injection i.v. Dotted line represents maximum number of nodules that could be counted. D. Melanin content of lungs. All data are shown as mean ± SEM. Statistical significance was calculated by one-way ANOVA followed by Tukey’s multiple comparison test.